The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.


Multiple Sclerosis: Shall We Target CD33?

TitleMultiple Sclerosis: Shall We Target CD33?
Publication TypeJournal Article
Year of Publication2020
AuthorsSiokas, V., Tsouris Z., Aloizou A-M., Bakirtzis C., Liampas I., Koutsis G., Anagnostouli M., Bogdanos D. P., Grigoriadis N., Hadjigeorgiou G. M., & Dardiotis E.
JournalGenes (Basel)
Date Published2020 Nov 12

BACKGROUND: Multiple sclerosis (MS) is a chronic disease of the central nervous system (CNS). Myeloid lineage cells (microglia and macrophages) may participate in the pathogenic mechanisms leading to MS. CD33 is a transmembrane receptor, mainly expressed by myeloid lineage cells. CD33 rs3865444 is a promoter variant previously associated with Alzheimer's disease, whose role in MS remains obscure.OBJECTIVE: To assess the role of CD33 rs3865444 in MS risk.METHODS: We genotyped 1396 patients with MS and 400 healthy controls for the presence of the CD33 rs3865444 variant. Odds ratios (ORs) with the respective 95% confidence intervals (CIs), were calculated with the SNPStats software, assuming five genetic models (co-dominant, dominant, recessive, over-dominant, and log-additive), with the G allele as the reference allele. The value of 0.05 was set as the threshold for statistical significance.RESULTS: CD33 rs3865444 was associated with MS risk in the dominant (GG vs. GT + TT; OR (95% C.I.) = 0.79 (0.63-0.99), = 0.041) and the over-dominant (GG + TT vs. GT; OR (95% C.I.) = 0.77 (0.61-0.97), = 0.03) modes of inheritance. Given that the GG genotype was more frequent and the GT genotype was less frequent in MS patients compared to controls-while the observed frequency of the TT genotype did not differ between the two groups-the observed difference in MS risk may be stemming from either the GG (as a risk factor) or the GT (as a protective factor) genotype of CD33 rs3865444.CONCLUSIONS: Our preliminary results suggest a possible contribution of CD33 rs3865444 to MS. Therefore, larger multiethnic studies should be conducted, investigating the role of CD33 rs3865444 in MS.

Alternate JournalGenes (Basel)
PubMed ID33198164
PubMed Central IDPMC7696272
Grant Listcode: 5287 / / Inn part by a research grant from the Research Committee of the University of Thessaly, Greece (code: 5287). /


Secretariat of the School of Medicine


School of Medicine's presence in social networks
Follow Us or Connect with us.